No Detail Found!

Neurological Recovery with Interferon-gamma Treatment in Friedreich's Ataxia

Author(s)
Hande Gazeteci Tekin Department of Pediatric Neurology, Bakircay University Cigli Training and Education Hospital,Yeni Mahalle Ata Sanayi, Cigli, Izmir,Turkey
Erturk Levent Department of Pediatric Cardiology, Ege University, Ege Universitesi Hastanesi Bornova,Izmir,Turkey
Abstract
Friedreich's ataxia (FA) is a rare, progressive, and degenerative hereditary disorder caused by a de ciency of frataxin protein. This disease is characterised by severe neurological dysfunction and life-threatening cardiomyopathy. Various drugs are used to slow down / stop the neurodegenerative progress. However, recent clinical trials and animal experiments demonstrate that interferon-gamma (IFN-c) treatment might improve signs of FA as well. A 9-year-old girl was admitted to our hospital with gait instability, mild dysarthria, and sensorimotor polyneuropathy. Her genetic examination was consistent with FA. IFN-c treatment was started 3 times a week. The treatment was evaluated by physical examination and side e ects assessment. Friedreich Ataxia Rating Scale (FARS), 9hole peg test (9HPT), and time of 25-foot walk (T25FW) were measured. Ataxia and cerebellar ndings improved within 9 months. Although clinical neurological improvement was achieved, there was no improvement in cardiomyopathy.
Publication Details
Page(s) 671-673
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 5, Year: 2022

Request the full text from PASTIC

Keywords
Children, Cardiomyopathy, Friedreich ataxia, Interferon-gamma, FARS
0

Citations

0

Downloads

77

Views